Kanglin Biotechnology Announces $20 Million Series A Financing to Advance the Development of Gene Therapies
November 25, 2024 07:00 ET
|
Kanglin Biotec
- Phase 1 study and Investigator Initiated Trial evaluating KL003 for patients with beta thalassemia demonstrated an encouraging efficacy signal and favorable safety profile – - Manufacturing costs...
Sickle Cell Disease Market Reach USD 12.38 Bn by 2032, Set to Grow Remarkable CAGR of 20.00% from 2024-2032
November 07, 2024 05:49 ET
|
Introspective Market Research
Mexico, Mexico City, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Introspective Market Research has published a comprehensive report on the Global Sickle Cell Disease (SCD) Market, highlighting an expected...
AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose
October 28, 2024 12:47 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS D'ACCEPTATION POUR LE BREVET EUROPÉEN COUVRANT JUSQU'EN 2040 LE MASITINIB DANS LE TRAITEMENT DE LA DREPANOCYTOSE CETTE DÉCISION...
AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease
October 28, 2024 12:47 ET
|
AB Science
PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS...
Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising Advances in Gene Therapies
August 28, 2024 10:14 ET
|
Spherix Global Insights
EXTON, PA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Despite advancements in treatments, sickle cell disease and thalassemia continue to present significant challenges for patients and healthcare providers....
American Institutes for Research To Help Implement Federal Program Aimed at Increasing Access to Transformative Cell and Gene Therapy Treatments
August 21, 2024 12:00 ET
|
American Institutes for Research
Arlington, Va., Aug. 21, 2024 (GLOBE NEWSWIRE) -- The American Institutes for Research (AIR) has been awarded a federal contract to help implement and monitor a new program that seeks to make...
Global Sickle Cell Anemia Testing & Screening Market Analysis and Forecast 2024-2030 - Rising Focus on Development of Non-Invasive, Hand-Held, and Digital Technologies
June 14, 2024 05:23 ET
|
Research and Markets
Dublin, June 14, 2024 (GLOBE NEWSWIRE) -- The "Global Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC),...
Spherix Global Insights Expands Therapeutic Area Coverage into Hematology
June 10, 2024 04:00 ET
|
Spherix Global Insights
EXTON, PA, June 10, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
December 02, 2023 12:59 ET
|
National Health Regulatory Authority
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
AB Science tiendra une conférence virtuelle le jeudi 30 novembre 2023, de 15h à 16h, pour présenter le programme de développement clinique du masitinib dans la drépanocytose.
November 28, 2023 13:22 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE SUR LE JEUDI 30 NOVEMBRE 2023, DE 15H A 16H, SUR LE PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA DREPANOCYTOSE Paris, 28...